Rock Creek Pharmaceuticals Inc. (fka RCPIQ)

[haysaw]

I'm bewildered as to why you are continuing to obsess over this. Most of what you are suggesting Jenkins do was already written in the article. In fact, the article revolves around the fact that they (Rock Creek) have commenced and continue to stay the course with the Euro clinical trials of Anatabine Citrate. I'm glad Jenkins didn't say they were "excited" about the main compound, or reiterate the facts in the article (continuing to pursue blah blah blah). It would have been cliché and boilerplate, respectively.